The FASEB Journal, Vol 6, 2698-2706, Copyright © 1992 by The Federation of American Societies for Experimental Biology

REVIEWS

Does chemically induced hepatocyte proliferation predict liver carcinogenesis?

RL Melnick
National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709.

Cell proliferation has long been recognized as having an important role in chemically induced carcinogenesis. Based on findings that certain nongenotoxic chemical carcinogens induced cell proliferation in the same organ that had an increased incidence of tumors, it has been hypothesized that a chemically induced response of enhanced DNA synthesis and cellular division causes cancer by increasing the rate of spontaneous mutations. It was further suggested that there would be no increased human risk of cancer by non-DNA-reactive compounds at doses that do not cause a proliferative response. An evaluation of the literature on the relationship between chemically induced cell proliferation and liver carcinogenesis reveals that very few systematic cell proliferation studies have been conducted over periods of extended exposure, and in many cases the exposure concentrations were not similar to those used in the cancer studies. The proliferative response resulting from exposure to many nongenotoxic carcinogens is not well sustained, whereas the carcinogenic response by these chemicals often requires prolonged exposure. The available literature leads to the conclusion that quantitative correspondences between cellular proliferation and carcinogenic responses have not been demonstrated and do not support the hypothesis that chemically induced cell proliferation is the primary mechanism by which nongenotoxic chemicals cause liver cancer. Studies of liver carcinogenesis in two-stage models point out the need to better understand chemical effects on cell loss as well as on cell replication, and demonstrate that measurements of cell proliferation alone are not sufficient to elucidate mechanisms of tumor development.

This article has been cited by other articles:

				M. M. Elrick, J. A. Kramer, C. L. Alden, E. A. G. Blomme, R. T. Bunch, M. A. Cabonce, S. W. Curtiss, L. D. Kier, K. L. Kolaja, C. P. Rodi, et al. Differential Display in Rat Livers Treated for 13 Weeks with Phenobarbital Implicates a Role for Metabolic and Oxidative Stress in Nongenotoxic Carcinogenicity Toxicol Pathol, January 1, 2005; 33(1): 118 - 126. [Abstract] [Full Text] [PDF]

				R.R. Maronpot, G. Flake, and A. J. Huff Relevance of Animal Carcinogenesis Findings to Human Cancer Predictions and Prevention Toxicol Pathol, January 1, 2004; 32(1_suppl): 40 - 48. [Abstract] [PDF]

				G. M. Ledda-Columbano, A. Perra, D. Concas, C. Cossu, F. Molotzu, C. Sartori, H. Shinozuka, and A. Columbano Different Effects of the Liver Mitogens Triiodo-Thyronine and Ciprofibrate on the Development of Rat Hepatocellular Carcinoma Toxicol Pathol, January 1, 2003; 31(1): 113 - 120. [Abstract] [PDF]

				J. R. Foster Cell Death and Cell Proliferation in the Control of Normal and Neoplastic Tissue Growth Toxicol Pathol, May 1, 2000; 28(3): 441 - 446. [Abstract] [PDF]

				G. M. Ledda-Columbano, A. Perra, R. Loi, H. Shinozuka, and A. Columbano Cell Proliferation Induced by Triiodothyronine in Rat Liver Is Associated with Nodule Regression and Reduction of Hepatocellular Carcinomas Cancer Res., February 1, 2000; 60(3): 603 - 609. [Abstract] [Full Text]

				G.M. Ledda-Columbano, A. Perra, R. Piga, M. Pibiri, R. Loi, H. Shinozuka, and A. Columbano Cell proliferation induced by 3,3',5-triiodo-L-thyronine is associated with a reduction in the number of preneoplastic hepatic lesions Carcinogenesis, December 1, 1999; 20(12): 2299 - 2304. [Abstract] [Full Text] [PDF]

				J. Ashby, A. Brady, C.R. Elcombe, B.M. Elliott, J. Ishmael, J. Odum, J.D. Tugwood, S. Kettle, and I.F.H. Purchase Mechanistically-based Human Hazard Assessment of Peroxisome Proliferator-induced Hepatocarcinogenesis Human and Experimental Toxicology, January 1, 1994; 13(2_suppl): S1 - S117. [PDF]